Chronic hypoxia promotes an aggressive phenotype in rat prostate cancer cells.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 17577739)

Published in Free Radic Res on July 01, 2007

Authors

Omar Alqawi1, Hong P Wang, Myrna Espiritu, Gurmit Singh

Author Affiliations

1: Department of Pathology and Molecular Medicine, Juravinski cancer Centre, McMaster University, Hamilton, Ont., Canada.

Articles by these authors

Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney. Eur Urol (2008) 2.42

Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int J Radiat Oncol Biol Phys (2010) 1.89

Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells. PLoS One (2012) 1.38

Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells. Photochem Photobiol (2005) 1.37

Overexpression of vimentin: role in the invasive phenotype in an androgen-independent model of prostate cancer. Cancer Res (2003) 1.32

ets-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element. FASEB J (2005) 1.18

Doxycycline and other tetracyclines in the treatment of bone metastasis. Anticancer Drugs (2003) 1.13

Giant cell tumor of bone: a basic science perspective. Bone (2012) 1.11

Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer. Cancer Res (2002) 1.10

Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. Neoplasia (2007) 1.05

Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer. Can J Physiol Pharmacol (2010) 1.01

Cancer cell lines release glutamate into the extracellular environment. Clin Exp Metastasis (2009) 1.00

Cancer cells release glutamate via the cystine/glutamate antiporter. Biochem Biophys Res Commun (2009) 0.99

Properties of the stromal cell in giant cell tumor of bone. Clin Orthop Relat Res (2007) 0.98

Regulation of the cell cycle in response to inhibition of mitochondrial generated energy. Biochem Biophys Res Commun (2005) 0.97

Role of IGF-1/IGF-1R in regulation of invasion in DU145 prostate cancer cells. Cancer Cell Int (2008) 0.96

Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells. BMC Cancer (2011) 0.95

High activity of mitochondrial glycerophosphate dehydrogenase and glycerophosphate-dependent ROS production in prostate cancer cell lines. Biochem Biophys Res Commun (2005) 0.95

Ionizing radiation regulates the expression of AMP-activated protein kinase (AMPK) in epithelial cancer cells: modulation of cellular signals regulating cell cycle and survival. Radiother Oncol (2012) 0.95

Overexpression of manganese superoxide dismutase promotes the survival of prostate cancer cells exposed to hyperthermia. Free Radic Res (2004) 0.95

The importance of social and collaborative learning for online continuing medical education (OCME): directions for future development and research. Med Teach (2012) 0.95

Comparing beta-carotene, vitamin E and nitric oxide as membrane antioxidants. Biol Chem (2002) 0.94

Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors. J Lab Clin Med (2006) 0.94

Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways. Radiat Oncol (2011) 0.92

Design, synthesis, and evaluation of novel 6-chloro-/fluorochromone derivatives as potential topoisomerase inhibitor anticancer agents. Bioorg Med Chem Lett (2005) 0.92

Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy. Cancer Res (2002) 0.90

Upregulation of MMP-13 via Runx2 in the stromal cell of Giant Cell Tumor of bone. Bone (2009) 0.90

Observations on the use of the avian chorioallantoic membrane (CAM) model in investigations into angiogenesis. Curr Drug Targets Cardiovasc Haematol Disord (2003) 0.90

Ets-1 global gene expression profile reveals associations with metabolism and oxidative stress in ovarian and breast cancers. Cancer Metab (2013) 0.90

Prediction and analysis of paralogous proteins in Trichomonas vaginalis genome. Bioinformation (2011) 0.90

Simultaneous determination of (fluoro)quinolone antibiotics in kidney, marine products, eggs, and muscle by enzyme-linked immunosorbent assay (ELISA). J Agric Food Chem (2006) 0.90

Collagenase expression and activity in the stromal cells from giant cell tumour of bone. Bone (2009) 0.89

Ets-1 regulates energy metabolism in cancer cells. PLoS One (2010) 0.89

Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells. Anticancer Drugs (2009) 0.89

Relationship between mTHPC fluorescence photobleaching and cell viability during in vitro photodynamic treatment of DP16 cells. Photochem Photobiol (2002) 0.89

Association of phosphorylated epidermal growth factor receptor with survival in patients with locally advanced non-small cell lung cancer treated with radiotherapy. J Thorac Oncol (2008) 0.89

Role of the transcription factor Ets-1 in cisplatin resistance. Mol Cancer Ther (2004) 0.88

Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells. Biochem Biophys Res Commun (2011) 0.88

Lovastatin sensitizes lung cancer cells to ionizing radiation: modulation of molecular pathways of radioresistance and tumor suppression. J Thorac Oncol (2011) 0.88

Glutamate signaling in healthy and diseased bone. Front Endocrinol (Lausanne) (2012) 0.88

L-PhGPx expression can be suppressed by antisense oligodeoxynucleotides. Arch Biochem Biophys (2003) 0.88

Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: a mechanistic model supporting prevention strategies. Int J Oncol (2010) 0.86

Increased expression of mitochondrial glycerophosphate dehydrogenase and antioxidant enzymes in prostate cancer cell lines/cancer. Free Radic Res (2007) 0.86

PTHrP induces autocrine/paracrine proliferation of bone tumor cells through inhibition of apoptosis. PLoS One (2011) 0.85

Up-regulation of Hsp27 plays a role in the resistance of human colon carcinoma HT29 cells to photooxidative stress. Photochem Photobiol (2002) 0.85

Role of insulin-like growth factor binding proteins (IGFBPs) in breast cancer proliferation and metastasis. Clin Exp Metastasis (2003) 0.85

Potential therapeutic drug target identification in Community Acquired-Methicillin Resistant Staphylococcus aureus (CA-MRSA) using computational analysis. Bioinformation (2012) 0.84

Effect of Herceptin on the development and progression of skeletal metastases in a xenograft model of human breast cancer. Oncogene (2005) 0.84

PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone. J Orthop Res (2011) 0.84

Extracellular glutamate alters mature osteoclast and osteoblast functions. Can J Physiol Pharmacol (2010) 0.84

Characterization of a rat model of metastatic prostate cancer bone pain. J Pain Res (2010) 0.84

ETS proteins and MMPs: partners in invasion and metastasis. Curr Drug Targets (2002) 0.84

Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone. Hum Pathol (2010) 0.83

Inhibition by doxycycline of angiogenesis in the chicken chorioallantoic membrane (CAM). Cancer Chemother Pharmacol (2005) 0.83

AP-1 as a Regulator of MMP-13 in the Stromal Cell of Giant Cell Tumor of Bone. Biochem Res Int (2011) 0.82

Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells. Breast Cancer Res Treat (2002) 0.82

Evaluation of single amino acid chelate derivatives and regioselective radiolabelling of a cyclic peptide for the urokinase plasminogen activator receptor. Nucl Med Biol (2009) 0.82

Metabolic pathway analysis and molecular docking analysis for identification of putative drug targets in Toxoplasma gondii: novel approach. Bioinformation (2012) 0.81

Chronic modulation of AMP-Kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts. Radiat Oncol (2012) 0.80

Activation of the stress-activated JNK and p38 MAP kinases in human cells by Photofrin-mediated photodynamic therapy. J Photochem Photobiol B (2003) 0.80

Androgen-dependent regulation of medium and long chain fatty acids uptake in prostate cancer. Prostate (2007) 0.80

Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity. J Lab Clin Med (2004) 0.80

Examination of the mechanisms of osteolysis in patients with metastatic breast cancer. Oncol Rep (2009) 0.80

JNK1 activity lowers the cellular production of H2O2 and modulates the growth arrest response to scavenging of H2O2 by catalase. Exp Cell Res (2003) 0.79

Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells. Photochem Photobiol (2005) 0.78

Metronomic PDT and cell death pathways. Methods Mol Biol (2010) 0.78

Oxidative stress and cancer pain. Can J Physiol Pharmacol (2013) 0.78

Molecular modeling, dynamics studies and virtual screening of Fructose 1, 6 biphosphate aldolase-II in community acquired- methicillin resistant Staphylococcus aureus (CA-MRSA). Bioinformation (2013) 0.78

Matrix Metalloproteinase Activity in the Stromal Cell of Giant Cell Tumor of Bone. Open Bone J (2009) 0.78

Quantification of anti-angiogenesis using the capillaries of the chick chorioallantoic membrane demonstrates that the effect of human angiostatin is age-dependent. Microvasc Res (2004) 0.78

Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells. Mol Cell Biochem (2015) 0.78

The role of TWIST as a regulator in giant cell tumor of bone. J Cell Biochem (2011) 0.78

Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells. Breast Cancer Res (2005) 0.77

A by-product of glutathione production in cancer cells may cause disruption in bone metabolic processes. Can J Physiol Pharmacol (2010) 0.77

Angiostatin II is the predominant glycoform in pleural effusates of rabbit VX-2 lung tumors. J Lab Clin Med (2002) 0.77

Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model. Cardiovasc Pathol (2007) 0.77

Increased BNip3 and decreased mutant p53 in cisplatin-sensitive PDT-resistant HT29 cells. Biochem Biophys Res Commun (2005) 0.77

Cancer-induced oxidative stress and pain. Curr Pain Headache Rep (2014) 0.77

Insight into trichomonas vaginalis genome evolution through metabolic pathways comparison. Bioinformation (2012) 0.76

A robust strategy for the preparation of libraries of metallopeptides. A new paradigm for the discovery of targeted molecular imaging and therapy agents. Chem Commun (Camb) (2008) 0.76

A dynamic human health risk assessment system. Toxicol Int (2012) 0.75

In vitro survival of nonsmall cell lung cancer cells following combined treatment with ionizing radiation and photofrin-mediated photodynamic therapy. Photochem Photobiol (2008) 0.75

Mitochondria and cancer. Biomed Res Int (2013) 0.75

Photochemical pinacol rearrangements of unsymmetrical diols. J Org Chem (2004) 0.75

T cells stimulate catabolic gene expression by the stromal cells from giant cell tumor of bone. Biochem Biophys Res Commun (2012) 0.75

Are we missing the potential of action research for transformative change in medical education? Educ Prim Care (2012) 0.75

Photochemistry of arylidene-beta-ionones: a highly efficient route to novel tricyclic ketones through intramolecular, exoselective photochemical (4 + 2) cycloadditions, occurring only in an aqueous-organic solvent. J Org Chem (2002) 0.75